The majority of patients carry mutations in either Endoglin (ENG) or ACVRL1 (also known as ALK1) genes, and the disease is characterized by arteriovenous malformations and persistent haemorrhage. This evidence concerns the gene ACVRL1 and arteriovenous hemangioma/malformation.